Literature DB >> 26307654

Genome-wide association study of prostate cancer-specific survival.

Robert Szulkin1, Robert Karlsson2, Thomas Whitington2, Markus Aly2, Henrik Gronberg2, Rosalind A Eeles3, Douglas F Easton4, Zsofia Kote-Jarai5, Ali Amin Al Olama4, Sara Benlloch4, Kenneth Muir6, Graham G Giles7, Melissa C Southey8, Liesel M FitzGerald9, Brian E Henderson10, Fredrick R Schumacher10, Christopher A Haiman10, Csilla Sipeky11, Teuvo L J Tammela12, Børge G Nordestgaard13, Timothy J Key14, Ruth C Travis14, David E Neal15, Jenny L Donovan16, Freddie C Hamdy17, Paul D P Pharoah18, Nora Pashayan19, Kay-Tee Khaw20, Janet L Stanford21, Stephen N Thibodeau22, Shannon K McDonnell22, Daniel J Schaid22, Christiane Maier23, Walther Vogel24, Manuel Luedeke23, Kathleen Herkommer25, Adam S Kibel26, Cezary Cybulski27, Jan Lubiński27, Wojciech Kluźniak27, Lisa Cannon-Albright28, Hermann Brenner29, Volker Herrmann30, Bernd Holleczek31, Jong Y Park32, Thomas A Sellers32, Hui-Yi Lim33, Chavdar Slavov34, Radka P Kaneva35, Vanio I Mitev35, Amanda Spurdle36, Manuel R Teixeira37, Paula Paulo38, Sofia Maia38, Hardev Pandha39, Agnieszka Michael39, Andrzej Kierzek39, Jyotsna Batra40, Judith A Clements40, Demetrius Albanes41, Gerald L Andriole42, Sonja I Berndt41, Stephen Chanock43, Susan M Gapstur44, Edward L Giovannucci45, David J Hunter46, Peter Kraft46, Loic Le Marchand47, Jing Ma48, Alison M Mondul41, Kathryn L Penney48, Meir J Stampfer49, Victoria L Stevens44, Stephanie J Weinstein41, Antonia Trichopoulou50, Bas H Bueno-de-Mesquita51, Anne Tjønneland52, David G Cox53, Lovise Maehle54, Johanna Schleutker55, Sara Lindström46, Fredrik Wiklund2.   

Abstract

BACKGROUND: Unnecessary intervention and overtreatment of indolent disease are common challenges in clinical management of prostate cancer. Improved tools to distinguish lethal from indolent disease are critical.
METHODS: We performed a genome-wide survival analysis of cause-specific death in 24,023 prostate cancer patients (3,513 disease-specific deaths) from the PRACTICAL and BPC3 consortia. Top findings were assessed for replication in a Norwegian cohort (CONOR).
RESULTS: We observed no significant association between genetic variants and prostate cancer survival.
CONCLUSIONS: Common genetic variants with large impact on prostate cancer survival were not observed in this study. IMPACT: Future studies should be designed for identification of rare variants with large effect sizes or common variants with small effect sizes. ©2015 American Association for Cancer Research.

Entities:  

Mesh：

Year:  2015        PMID： 26307654      PMCID： PMC5674990          DOI： 10.1158/1055-9965.EPI-15-0543

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


  8 in total

1.  Computing the Cox model for case cohort designs.

Authors:  T M Therneau; H Li
Journal:  Lifetime Data Anal       Date:  1999-06       Impact factor: 1.588

2.  Genome-wide association study of prostate cancer mortality.

Authors:  Kathryn L Penney; Saumyadipta Pyne; Fredrick R Schumacher; Jennifer A Sinnott; Lorelei A Mucci; Peter L Kraft; Jing Ma; William K Oh; Tobias Kurth; Philip W Kantoff; Edward L Giovannucci; Meir J Stampfer; David J Hunter; Matthew L Freedman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-26       Impact factor: 4.254

3.  Practical aspects of imputation-driven meta-analysis of genome-wide association studies.

Authors:  Paul I W de Bakker; Manuel A R Ferreira; Xiaoming Jia; Benjamin M Neale; Soumya Raychaudhuri; Benjamin F Voight
Journal:  Hum Mol Genet       Date:  2008-10-15       Impact factor: 6.150

4.  Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

Authors:  Jonas Hugosson; Sigrid Carlsson; Gunnar Aus; Svante Bergdahl; Ali Khatami; Pär Lodding; Carl-Gustaf Pihl; Johan Stranne; Erik Holmberg; Hans Lilja
Journal:  Lancet Oncol       Date:  2010-07-02       Impact factor: 41.316

5.  Genome-wide association study identifies new prostate cancer susceptibility loci.

Authors:  Fredrick R Schumacher; Sonja I Berndt; Afshan Siddiq; Kevin B Jacobs; Zhaoming Wang; Sara Lindstrom; Victoria L Stevens; Constance Chen; Alison M Mondul; Ruth C Travis; Daniel O Stram; Rosalind A Eeles; Douglas F Easton; Graham Giles; John L Hopper; David E Neal; Freddie C Hamdy; Jenny L Donovan; Kenneth Muir; Ali Amin Al Olama; Zsofia Kote-Jarai; Michelle Guy; Gianluca Severi; Henrik Grönberg; William B Isaacs; Robert Karlsson; Fredrik Wiklund; Jianfeng Xu; Naomi E Allen; Gerald L Andriole; Aurelio Barricarte; Heiner Boeing; H Bas Bueno-de-Mesquita; E David Crawford; W Ryan Diver; Carlos A Gonzalez; J Michael Gaziano; Edward L Giovannucci; Mattias Johansson; Loic Le Marchand; Jing Ma; Sabina Sieri; Pär Stattin; Meir J Stampfer; Anne Tjonneland; Paolo Vineis; Jarmo Virtamo; Ulla Vogel; Stephanie J Weinstein; Meredith Yeager; Michael J Thun; Laurence N Kolonel; Brian E Henderson; Demetrius Albanes; Richard B Hayes; Heather Spencer Feigelson; Elio Riboli; David J Hunter; Stephen J Chanock; Christopher A Haiman; Peter Kraft
Journal:  Hum Mol Genet       Date:  2011-07-08       Impact factor: 6.150

6.  Familial concordance in cancer survival: a Swedish population-based study.

Authors:  Linda S Lindström; Per Hall; Mikael Hartman; Fredrik Wiklund; Henrik Grönberg; Kamila Czene
Journal:  Lancet Oncol       Date:  2007-10-24       Impact factor: 41.316

7.  Cohort profile: cohort of Norway (CONOR).

Authors:  Oyvind Naess; Anne Johanne Søgaard; Egil Arnesen; Anne Cathrine Beckstrøm; Espen Bjertness; Anders Engeland; Peter F Hjort; Jostein Holmen; Per Magnus; Inger Njølstad; Grethe S Tell; Lars Vatten; Stein Emil Vollset; Geir Aamodt
Journal:  Int J Epidemiol       Date:  2007-11-04       Impact factor: 7.196

8.  A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.

Authors:  Ali Amin Al Olama; Zsofia Kote-Jarai; Sonja I Berndt; David V Conti; Fredrick Schumacher; Ying Han; Sara Benlloch; Dennis J Hazelett; Zhaoming Wang; Ed Saunders; Daniel Leongamornlert; Sara Lindstrom; Sara Jugurnauth-Little; Tokhir Dadaev; Malgorzata Tymrakiewicz; Daniel O Stram; Kristin Rand; Peggy Wan; Alex Stram; Xin Sheng; Loreall C Pooler; Karen Park; Lucy Xia; Jonathan Tyrer; Laurence N Kolonel; Loic Le Marchand; Robert N Hoover; Mitchell J Machiela; Merideth Yeager; Laurie Burdette; Charles C Chung; Amy Hutchinson; Kai Yu; Chee Goh; Mahbubl Ahmed; Koveela Govindasami; Michelle Guy; Teuvo L J Tammela; Anssi Auvinen; Tiina Wahlfors; Johanna Schleutker; Tapio Visakorpi; Katri A Leinonen; Jianfeng Xu; Markus Aly; Jenny Donovan; Ruth C Travis; Tim J Key; Afshan Siddiq; Federico Canzian; Kay-Tee Khaw; Atsushi Takahashi; Michiaki Kubo; Paul Pharoah; Nora Pashayan; Maren Weischer; Borge G Nordestgaard; Sune F Nielsen; Peter Klarskov; Martin Andreas Røder; Peter Iversen; Stephen N Thibodeau; Shannon K McDonnell; Daniel J Schaid; Janet L Stanford; Suzanne Kolb; Sarah Holt; Beatrice Knudsen; Antonio Hurtado Coll; Susan M Gapstur; W Ryan Diver; Victoria L Stevens; Christiane Maier; Manuel Luedeke; Kathleen Herkommer; Antje E Rinckleb; Sara S Strom; Curtis Pettaway; Edward D Yeboah; Yao Tettey; Richard B Biritwum; Andrew A Adjei; Evelyn Tay; Ann Truelove; Shelley Niwa; Anand P Chokkalingam; Lisa Cannon-Albright; Cezary Cybulski; Dominika Wokołorczyk; Wojciech Kluźniak; Jong Park; Thomas Sellers; Hui-Yi Lin; William B Isaacs; Alan W Partin; Hermann Brenner; Aida Karina Dieffenbach; Christa Stegmaier; Constance Chen; Edward L Giovannucci; Jing Ma; Meir Stampfer; Kathryn L Penney; Lorelei Mucci; Esther M John; Sue A Ingles; Rick A Kittles; Adam B Murphy; Hardev Pandha; Agnieszka Michael; Andrzej M Kierzek; William Blot; Lisa B Signorello; Wei Zheng; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Barbara Nemesure; John Carpten; Cristina Leske; Suh-Yuh Wu; Anselm Hennis; Adam S Kibel; Benjamin A Rybicki; Christine Neslund-Dudas; Ann W Hsing; Lisa Chu; Phyllis J Goodman; Eric A Klein; S Lilly Zheng; Jyotsna Batra; Judith Clements; Amanda Spurdle; Manuel R Teixeira; Paula Paulo; Sofia Maia; Chavdar Slavov; Radka Kaneva; Vanio Mitev; John S Witte; Graham Casey; Elizabeth M Gillanders; Daniella Seminara; Elio Riboli; Freddie C Hamdy; Gerhard A Coetzee; Qiyuan Li; Matthew L Freedman; David J Hunter; Kenneth Muir; Henrik Gronberg; David E Neal; Melissa Southey; Graham G Giles; Gianluca Severi; Michael B Cook; Hidewaki Nakagawa; Fredrik Wiklund; Peter Kraft; Stephen J Chanock; Brian E Henderson; Douglas F Easton; Rosalind A Eeles; Christopher A Haiman
Journal:  Nat Genet       Date:  2014-09-14       Impact factor: 38.330
  8 in total
  16 in total

1.  Familial prostate cancer.

Authors:  Veda N Giri; Jennifer L Beebe-Dimmer
Journal:  Semin Oncol       Date:  2016-08-18       Impact factor: 4.929

2.  Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.

Authors:  Rong Na; S Lilly Zheng; Misop Han; Hongjie Yu; Deke Jiang; Sameep Shah; Charles M Ewing; Liti Zhang; Kristian Novakovic; Jacqueline Petkewicz; Kamalakar Gulukota; Donald L Helseth; Margo Quinn; Elizabeth Humphries; Kathleen E Wiley; Sarah D Isaacs; Yishuo Wu; Xu Liu; Ning Zhang; Chi-Hsiung Wang; Janardan Khandekar; Peter J Hulick; Daniel H Shevrin; Kathleen A Cooney; Zhoujun Shen; Alan W Partin; H Ballentine Carter; Michael A Carducci; Mario A Eisenberger; Sam R Denmeade; Michael McGuire; Patrick C Walsh; Brian T Helfand; Charles B Brendler; Qiang Ding; Jianfeng Xu; William B Isaacs
Journal:  Eur Urol       Date:  2016-12-15       Impact factor: 20.096

3.  Finding a Needle in the Haystack: The Search for Germline Variants Associated with Prostate Cancer Clinical Outcomes.

Authors:  Kathleen A Cooney; Jennifer L Beebe-Dimmer
Journal:  Eur Urol       Date:  2018-07-17       Impact factor: 20.096

4.  Genome-wide germline correlates of the epigenetic landscape of prostate cancer.

Authors:  Kathleen E Houlahan; Yu-Jia Shiah; Alexander Gusev; Jiapei Yuan; Musaddeque Ahmed; Anamay Shetty; Susmita G Ramanand; Cindy Q Yao; Connor Bell; Edward O'Connor; Vincent Huang; Michael Fraser; Lawrence E Heisler; Julie Livingstone; Takafumi N Yamaguchi; Alexandre Rouette; Adrien Foucal; Shadrielle Melijah G Espiritu; Ankit Sinha; Michelle Sam; Lee Timms; Jeremy Johns; Ada Wong; Alex Murison; Michèle Orain; Valérie Picard; Hélène Hovington; Alain Bergeron; Louis Lacombe; Mathieu Lupien; Yves Fradet; Bernard Têtu; John D McPherson; Bogdan Pasaniuc; Thomas Kislinger; Melvin L K Chua; Mark M Pomerantz; Theodorus van der Kwast; Matthew L Freedman; Ram S Mani; Housheng H He; Robert G Bristow; Paul C Boutros
Journal:  Nat Med       Date:  2019-10-07       Impact factor: 53.440

5.  Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival.

Authors:  Weiqiang Li; Mridu Middha; Mesude Bicak; Daniel D Sjoberg; Emily Vertosick; Anders Dahlin; Christel Häggström; Göran Hallmans; Ann-Charlotte Rönn; Pär Stattin; Olle Melander; David Ulmert; Hans Lilja; Robert J Klein
Journal:  Eur Urol       Date:  2018-07-07       Impact factor: 20.096

6.  Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes.

Authors:  Jennifer L Beebe-Dimmer; Ashley L Kapron; Alison M Fraser; Ken R Smith; Kathleen A Cooney
Journal:  J Clin Oncol       Date:  2020-03-24       Impact factor: 44.544

7.  Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.

Authors:  Freddie C Hamdy; Jenny L Donovan; J Athene Lane; Malcolm Mason; Chris Metcalfe; Peter Holding; Julia Wade; Sian Noble; Kirsty Garfield; Grace Young; Michael Davis; Tim J Peters; Emma L Turner; Richard M Martin; Jon Oxley; Mary Robinson; John Staffurth; Eleanor Walsh; Jane Blazeby; Richard Bryant; Prasad Bollina; James Catto; Andrew Doble; Alan Doherty; David Gillatt; Vincent Gnanapragasam; Owen Hughes; Roger Kockelbergh; Howard Kynaston; Alan Paul; Edgar Paez; Philip Powell; Stephen Prescott; Derek Rosario; Edward Rowe; David Neal
Journal:  Health Technol Assess       Date:  2020-08       Impact factor: 4.014

Review 8.  Causal Inference in Cancer Epidemiology: What Is the Role of Mendelian Randomization?

Authors:  James Yarmolinsky; Kaitlin H Wade; Rebecca C Richmond; Ryan J Langdon; Caroline J Bull; Kate M Tilling; Caroline L Relton; Sarah J Lewis; George Davey Smith; Richard M Martin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-06-25       Impact factor: 4.254

9.  Prognostic significance of fibroblast growth factor receptor 4 polymorphisms on biochemical recurrence after radical prostatectomy in a Chinese population.

Authors:  Luyao Chen; Zhengwei Lei; Xin Ma; Qingbo Huang; Xu Zhang; Yong Zhang; Peng Hao; Minggang Yang; Xuetao Zhao; Jun Chen; Gongxue Liu; Tao Zheng
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

10.  Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.

Authors:  Colin C Pritchard; Joaquin Mateo; Michael F Walsh; Navonil De Sarkar; Wassim Abida; Himisha Beltran; Andrea Garofalo; Roman Gulati; Suzanne Carreira; Rosalind Eeles; Olivier Elemento; Mark A Rubin; Dan Robinson; Robert Lonigro; Maha Hussain; Arul Chinnaiyan; Jake Vinson; Julie Filipenko; Levi Garraway; Mary-Ellen Taplin; Saud AlDubayan; G Celine Han; Mallory Beightol; Colm Morrissey; Belinda Nghiem; Heather H Cheng; Bruce Montgomery; Tom Walsh; Silvia Casadei; Michael Berger; Liying Zhang; Ahmet Zehir; Joseph Vijai; Howard I Scher; Charles Sawyers; Nikolaus Schultz; Philip W Kantoff; David Solit; Mark Robson; Eliezer M Van Allen; Kenneth Offit; Johann de Bono; Peter S Nelson
Journal:  N Engl J Med       Date:  2016-07-06       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.